Trials / Unknown
UnknownNCT01348256
Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma
Randomized Phase II Study With Dendritic Cell Immunotherapy in Patients With Resected Hepatic Metastasis of Colorectal Carcinoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 58 (estimated)
- Sponsor
- Clinica Universidad de Navarra, Universidad de Navarra · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this randomized multicentric phase II study, patients with colorectal carcinoma with resectable hepatic metastasis will be randomized to treatment with dendritic cells or to observation, following conventional treatment with surgery and chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dendritic cells vaccine | Vaccination with autologous dendritic cells loaded with autologous tumor antigens |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2011-05-05
- Last updated
- 2017-10-24
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01348256. Inclusion in this directory is not an endorsement.